APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cosmetic Peptide Manufacturing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Cosmetic Peptide Manufacturing Market Outlook and Growth Opportunities 2026

Report ID 17341220045 June 2026202 pages

Choose your research edition.

Industry ResearchCosmetic Peptide Manufacturing Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Cosmetic Peptide Manufacturing Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Cosmetic Peptide Manufacturing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cosmetic Peptide Manufacturing Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Cosmetic Peptide Manufacturing Market Analysis and Forecast 2026-2032233 pages · $4,950 USD

Market perspective

The global Cosmetic Peptide Manufacturing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Cosmetic Peptide Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cosmetic Peptide Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cosmetic Peptide Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Cosmetic Peptide Manufacturing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Cosmetic Peptide Manufacturing market include Croda International PIc, Ashland, DSM [Koninklijke DSM NV], Bachem, Genscript Biotech Corp, BASF SE, Geltor, The Lubrizol Corporation and Symrise, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Cosmetic Peptide Manufacturing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cosmetic Peptide Manufacturing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cosmetic Peptide Manufacturing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Cosmetic Peptide Manufacturing market.

Cosmetic Peptide Manufacturing Segment by Company

Croda International PIc

Ashland

DSM [Koninklijke DSM NV]

Bachem

Genscript Biotech Corp

BASF SE

Geltor

The Lubrizol Corporation

Symrise

Bio basic Inc.

Regeron Inc.

Merck KGaA

RS Synthesis, LLC

CSBio Company Inc.

Creative Peptides

Spec Chem Industry Inc.

LipoTrue, SL

Fibroheal

Seiwa Kasei Co., Ltd.

Silab

Cosmetic Peptide Manufacturing Segment by Type

Signal Peptides

Neurotransmitter Inhibitors

Carrier Peptides

Enzyme Inhibitor Peptides

Structural Peptides

Synthetic Antimicrobial Peptides (Amps)

Others

Cosmetic Peptide Manufacturing Segment by Application

Cosmetic Manufacturers

Cosmetic Contract Manufacturers

Biopharmaceutical Industries (Personal Care)

Cosmetic Peptide Manufacturing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Cosmetic Peptide Manufacturing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Cosmetic Peptide Manufacturing key companies, revenue, market share, and recent developments.

3. To split the Cosmetic Peptide Manufacturing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Cosmetic Peptide Manufacturing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cosmetic Peptide Manufacturing significant trends, drivers, influence factors in global and regions.

6. To analyze Cosmetic Peptide Manufacturing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cosmetic Peptide Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cosmetic Peptide Manufacturing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cosmetic Peptide Manufacturing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cosmetic Peptide Manufacturing industry.

Chapter 3: Detailed analysis of Cosmetic Peptide Manufacturing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Cosmetic Peptide Manufacturing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Cosmetic Peptide Manufacturing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cosmetic Peptide Manufacturing Industry Trends Table 2. Cosmetic Peptide Manufacturing Industry Drivers Table 3. Cosmetic Peptide Manufacturing Industry Opportunities and Challenges Table 4. Cosmetic Peptide Manufacturing Industry Restraints Table 5. Global Cosmetic Peptide Manufacturing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cosmetic Peptide Manufacturing Revenue Share by Company (2021-2026) Table 7. Global Cosmetic Peptide Manufacturing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Cosmetic Peptide Manufacturing Key Company Manufacturing Base & Headquarters Table 9. Global Cosmetic Peptide Manufacturing Company, Product Type & Application Table 10. Global Cosmetic Peptide Manufacturing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Cosmetic Peptide Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Signal Peptides Table 15. Significant Companies of Neurotransmitter Inhibitors Table 16. Significant Companies of Carrier Peptides Table 17. Significant Companies of Enzyme Inhibitor Peptides Table 18. Significant Companies of Structural Peptides Table 19. Significant Companies of Synthetic Antimicrobial Peptides (Amps) Table 20. Significant Companies of Others Table 21. Global Cosmetic Peptide Manufacturing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 22. Global Cosmetic Peptide Manufacturing Sales Value by Type (2021-2026) & (US$ Million) Table 23. Global Cosmetic Peptide Manufacturing Sales Value by Type (2027-2032) & (US$ Million) Table 24. Global Cosmetic Peptide Manufacturing Sales Value Share by Type (2021-2026) Table 25. Global Cosmetic Peptide Manufacturing Sales Value Share by Type (2027-2032) Table 26. Significant Companies of Cosmetic Manufacturers Table 27. Significant Companies of Cosmetic Contract Manufacturers Table 28. Significant Companies of Biopharmaceutical Industries (Personal Care) Table 29. Global Cosmetic Peptide Manufacturing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Cosmetic Peptide Manufacturing Sales Value by Application (2021-2026) & (US$ Million) Table 31. Global Cosmetic Peptide Manufacturing Sales Value by Application (2027-2032) & (US$ Million) Table 32. Global Cosmetic Peptide Manufacturing Sales Value Share by Application (2021-2026) Table 33. Global Cosmetic Peptide Manufacturing Sales Value Share by Application (2027-2032) Table 34. Global Cosmetic Peptide Manufacturing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Cosmetic Peptide Manufacturing Sales Value by Region (2021-2026) & (US$ Million) Table 36. Global Cosmetic Peptide Manufacturing Sales Value Share by Region (2021-2026) Table 37. Global Cosmetic Peptide Manufacturing Sales Value by Region (2027-2032) & (US$ Million) Table 38. Global Cosmetic Peptide Manufacturing Sales Value Share by Region (2027-2032) Table 39. Global Cosmetic Peptide Manufacturing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Cosmetic Peptide Manufacturing Sales Value by Country (2021-2026) & (US$ Million) Table 41. Global Cosmetic Peptide Manufacturing Sales Value Market Share by Country (2021-2026) Table 42. Global Cosmetic Peptide Manufacturing Sales Value by Country (2027-2032) & (US$ Million) Table 43. Global Cosmetic Peptide Manufacturing Sales Value Market Share by Country (2027-2032) Table 44. Croda International PIc Company Information Table 45. Croda International PIc Business Overview Table 46. Croda International PIc Cosmetic Peptide Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Croda International PIc Cosmetic Peptide Manufacturing Product Portfolio Table 48. Croda International PIc Recent Development Table 49. Ashland Company Information Table 50. Ashland Business Overview Table 51. Ashland Cosmetic Peptide Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Ashland Cosmetic Peptide Manufacturing Product Portfolio Table 53. Ashland Recent Development Table 54. DSM [Koninklijke DSM NV] Company Information Table 55. DSM [Koninklijke DSM NV] Business Overview Table 56. DSM [Koninklijke DSM NV] Cosmetic Peptide Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. DSM [Koninklijke DSM NV] Cosmetic Peptide Manufacturing Product Portfolio Table 58. DSM [Koninklijke DSM NV] Recent Development Table 59. Bachem Company Information Table 60. Bachem Business Overview Table 61. Bachem Cosmetic Peptide Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Bachem Cosmetic Peptide Manufacturing Product Portfolio Table 63. Bachem Recent Development Table 64. Genscript Biotech Corp Company Information Table 65. Genscript Biotech Corp Business Overview Table 66. Genscript Biotech Corp Cosmetic Peptide Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Genscript Biotech Corp Cosmetic Peptide Manufacturing Product Portfolio Table 68. Genscript Biotech Corp Recent Development Table 69. BASF SE Company Information Table 70. BASF SE Business Overview Table 71. BASF SE Cosmetic Peptide Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. BASF SE Cosmetic Peptide Manufacturing Product Portfolio Table 73. BASF SE Recent Development Table 74. Geltor Company Information Table 75. Geltor Business Overview Table 76. Geltor Cosmetic Peptide Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Geltor Cosmetic Peptide Manufacturing Product Portfolio Table 78. Geltor Recent Development Table 79. The Lubrizol Corporation Company Information Table 80. The Lubrizol Corporation Business Overview Table 81. The Lubrizol Corporation Cosmetic Peptide Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. The Lubrizol Corporation Cosmetic Peptide Manufacturing Product Portfolio Table 83. The Lubrizol Corporation Recent Development Table 84. Symrise Company Information Table 85. Symrise Business Overview Table 86. Symrise Cosmetic Peptide Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Symrise Cosmetic Peptide Manufacturing Product Portfolio Table 88. Symrise Recent Development Table 89. Bio basic Inc. Company Information Table 90. Bio basic Inc. Business Overview Table 91. Bio basic Inc. Cosmetic Peptide Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Bio basic Inc. Cosmetic Peptide Manufacturing Product Portfolio Table 93. Bio basic Inc. Recent Development Table 94. Regeron Inc. Company Information Table 95. Regeron Inc. Business Overview Table 96. Regeron Inc. Cosmetic Peptide Manufacturing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Regeron Inc. Cosmetic Peptide Manufacturing Product Portfolio Table 98. Regeron Inc. Recent Development Table 99. Merck KGaA Company Information Table 100. Merck KGaA Business Overview Table 101. Merck KGaA Cosmetic Peptide Manufacturing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Merck KGaA Cosmetic Peptide Manufacturing Product Portfolio Table 103. Merck KGaA Recent Development Table 104. RS Synthesis, LLC Company Information Table 105. RS Synthesis, LLC Business Overview Table 106. RS Synthesis, LLC Cosmetic Peptide Manufacturing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. RS Synthesis, LLC Cosmetic Peptide Manufacturing Product Portfolio Table 108. RS Synthesis, LLC Recent Development Table 109. CSBio Company Inc. Company Information Table 110. CSBio Company Inc. Business Overview Table 111. CSBio Company Inc. Cosmetic Peptide Manufacturing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. CSBio Company Inc. Cosmetic Peptide Manufacturing Product Portfolio Table 113. CSBio Company Inc. Recent Development Table 114. Creative Peptides Company Information Table 115. Creative Peptides Business Overview Table 116. Creative Peptides Cosmetic Peptide Manufacturing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Creative Peptides Cosmetic Peptide Manufacturing Product Portfolio Table 118. Creative Peptides Recent Development Table 119. Spec Chem Industry Inc. Company Information Table 120. Spec Chem Industry Inc. Business Overview Table 121. Spec Chem Industry Inc. Cosmetic Peptide Manufacturing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Spec Chem Industry Inc. Cosmetic Peptide Manufacturing Product Portfolio Table 123. Spec Chem Industry Inc. Recent Development Table 124. LipoTrue, SL Company Information Table 125. LipoTrue, SL Business Overview Table 126. LipoTrue, SL Cosmetic Peptide Manufacturing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. LipoTrue, SL Cosmetic Peptide Manufacturing Product Portfolio Table 128. LipoTrue, SL Recent Development Table 129. Fibroheal Company Information Table 130. Fibroheal Business Overview Table 131. Fibroheal Cosmetic Peptide Manufacturing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 132. Fibroheal Cosmetic Peptide Manufacturing Product Portfolio Table 133. Fibroheal Recent Development Table 134. Seiwa Kasei Co., Ltd. Company Information Table 135. Seiwa Kasei Co., Ltd. Business Overview Table 136. Seiwa Kasei Co., Ltd. Cosmetic Peptide Manufacturing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 137. Seiwa Kasei Co., Ltd. Cosmetic Peptide Manufacturing Product Portfolio Table 138. Seiwa Kasei Co., Ltd. Recent Development Table 139. Silab Company Information Table 140. Silab Business Overview Table 141. Silab Cosmetic Peptide Manufacturing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 142. Silab Cosmetic Peptide Manufacturing Product Portfolio Table 143. Silab Recent Development Table 144. Research Programs/Design for This Report Table 145. Authors List of This Report Table 146. Secondary Sources Table 147. Primary Sources List of Figures Figure 1. Cosmetic Peptide Manufacturing Product Image Figure 2. Global Cosmetic Peptide Manufacturing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cosmetic Peptide Manufacturing Market Size (2021-2032) & (US$ Million) Figure 4. Global Cosmetic Peptide Manufacturing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Signal Peptides Image Figure 8. Neurotransmitter Inhibitors Image Figure 9. Carrier Peptides Image Figure 10. Enzyme Inhibitor Peptides Image Figure 11. Structural Peptides Image Figure 12. Synthetic Antimicrobial Peptides (Amps) Image Figure 13. Others Image Figure 14. Global Cosmetic Peptide Manufacturing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Cosmetic Peptide Manufacturing Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Cosmetic Peptide Manufacturing Sales Value Share by Type (2021-2032) Figure 17. Cosmetic Manufacturers Image Figure 18. Cosmetic Contract Manufacturers Image Figure 19. Biopharmaceutical Industries (Personal Care) Image Figure 20. Global Cosmetic Peptide Manufacturing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Cosmetic Peptide Manufacturing Sales Value Share 2021 VS 2025 VS 2032 Figure 22. Global Cosmetic Peptide Manufacturing Sales Value Share by Application (2021-2032) Figure 23. Global Cosmetic Peptide Manufacturing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 24. Global Cosmetic Peptide Manufacturing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 25. North America Cosmetic Peptide Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 26. North America Cosmetic Peptide Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Europe Cosmetic Peptide Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 28. Europe Cosmetic Peptide Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Asia-Pacific Cosmetic Peptide Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 30. Asia-Pacific Cosmetic Peptide Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 31. South America Cosmetic Peptide Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 32. South America Cosmetic Peptide Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Middle East & Africa Cosmetic Peptide Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 34. Middle East & Africa Cosmetic Peptide Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 35. USA Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. USA Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. USA Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Canada Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Canada Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Canada Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Mexico Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Mexico Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Mexico Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Germany Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Germany Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Germany Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. France Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. France Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. France Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. U.K. Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. U.K. Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. U.K. Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Italy Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Italy Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Italy Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Spain Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Spain Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Spain Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Russia Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Russia Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Russia Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Netherlands Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Netherlands Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Netherlands Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Nordic Countries Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Nordic Countries Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Nordic Countries Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. China Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. China Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. China Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Japan Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Japan Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Japan Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. South Korea Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. South Korea Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. South Korea Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. India Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. India Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. India Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Australia Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Australia Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Australia Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Southeast Asia Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Southeast Asia Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Southeast Asia Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Brazil Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Brazil Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Brazil Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Argentina Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Argentina Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Argentina Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Chile Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Chile Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Chile Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Colombia Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Colombia Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Colombia Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Peru Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Peru Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Peru Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Saudi Arabia Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Saudi Arabia Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Israel Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Israel Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Israel Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. UAE Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. UAE Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. UAE Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Turkey Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Turkey Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Turkey Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Iran Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Iran Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Iran Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Egypt Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Egypt Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Egypt Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Years Considered Figure 120. Research Process Figure 121. Key Executives Interviewed

Scope & coverage.

Types
  • Signal Peptides
  • Neurotransmitter Inhibitors
  • Carrier Peptides
  • Enzyme Inhibitor Peptides
  • Structural Peptides
  • Synthetic Antimicrobial Peptides (Amps)
  • Others
Applications
  • Cosmetic Manufacturers
  • Cosmetic Contract Manufacturers
  • Biopharmaceutical Industries (Personal Care)
Companies covered
  • Croda International PIc
  • Ashland
  • DSM [Koninklijke DSM NV]
  • Bachem
  • Genscript Biotech Corp
  • BASF SE
  • Geltor
  • The Lubrizol Corporation
  • Symrise
  • Bio basic Inc.
  • Regeron Inc.
  • Merck KGaA
  • RS Synthesis, LLC
  • CSBio Company Inc.
  • Creative Peptides
  • Spec Chem Industry Inc.
  • LipoTrue, SL
  • Fibroheal
  • Seiwa Kasei Co., Ltd.
  • Silab

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cosmetic Peptide Manufacturing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cosmetic Peptide Manufacturing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Cosmetic Peptide Manufacturing Market Dynamics
  1. 2.1 Cosmetic Peptide Manufacturing Industry Trends
  2. 2.2 Cosmetic Peptide Manufacturing Industry Drivers
  3. 2.3 Cosmetic Peptide Manufacturing Industry Opportunities and Challenges
  4. 2.4 Cosmetic Peptide Manufacturing Industry Restraints
3 Cosmetic Peptide Manufacturing Market by Company
  1. 3.1 Global Cosmetic Peptide Manufacturing Company Revenue Ranking in 2025
  2. 3.2 Global Cosmetic Peptide Manufacturing Revenue by Company (2021-2026)
  3. 3.3 Global Cosmetic Peptide Manufacturing Company Ranking (2024-2026)
  4. 3.4 Global Cosmetic Peptide Manufacturing Company Manufacturing Base and Headquarters
  5. 3.5 Global Cosmetic Peptide Manufacturing Company Product Type and Application
  6. 3.6 Global Cosmetic Peptide Manufacturing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Cosmetic Peptide Manufacturing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Cosmetic Peptide Manufacturing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Cosmetic Peptide Manufacturing Market by Type
  1. 4.1 Cosmetic Peptide Manufacturing Type Introduction
  2. 4.1.1 Signal Peptides
  3. 4.1.2 Neurotransmitter Inhibitors
  4. 4.1.3 Carrier Peptides
  5. 4.1.4 Enzyme Inhibitor Peptides
  6. 4.1.5 Structural Peptides
  7. 4.1.6 Synthetic Antimicrobial Peptides (Amps)
  8. 4.1.7 Others
  9. 4.2 Global Cosmetic Peptide Manufacturing Sales Value by Type
  10. 4.2.1 Global Cosmetic Peptide Manufacturing Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Cosmetic Peptide Manufacturing Sales Value by Type (2021-2032)
  12. 4.2.3 Global Cosmetic Peptide Manufacturing Sales Value Share by Type (2021-2032)
5 Cosmetic Peptide Manufacturing Market by Application
  1. 5.1 Cosmetic Peptide Manufacturing Application Introduction
  2. 5.1.1 Cosmetic Manufacturers
  3. 5.1.2 Cosmetic Contract Manufacturers
  4. 5.1.3 Biopharmaceutical Industries (Personal Care)
  5. 5.2 Global Cosmetic Peptide Manufacturing Sales Value by Application
  6. 5.2.1 Global Cosmetic Peptide Manufacturing Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Cosmetic Peptide Manufacturing Sales Value by Application (2021-2032)
  8. 5.2.3 Global Cosmetic Peptide Manufacturing Sales Value Share by Application (2021-2032)
6 Cosmetic Peptide Manufacturing Regional Value Analysis
  1. 6.1 Global Cosmetic Peptide Manufacturing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cosmetic Peptide Manufacturing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Cosmetic Peptide Manufacturing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Cosmetic Peptide Manufacturing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cosmetic Peptide Manufacturing Sales Value (2021-2032)
  7. 6.3.2 North America Cosmetic Peptide Manufacturing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Cosmetic Peptide Manufacturing Sales Value (2021-2032)
  10. 6.4.2 Europe Cosmetic Peptide Manufacturing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Cosmetic Peptide Manufacturing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Cosmetic Peptide Manufacturing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Cosmetic Peptide Manufacturing Sales Value (2021-2032)
  16. 6.6.2 South America Cosmetic Peptide Manufacturing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Cosmetic Peptide Manufacturing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Cosmetic Peptide Manufacturing Sales Value Share by Country, 2025 VS 2032
7 Cosmetic Peptide Manufacturing Country-level Value Analysis
  1. 7.1 Global Cosmetic Peptide Manufacturing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cosmetic Peptide Manufacturing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Cosmetic Peptide Manufacturing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Cosmetic Peptide Manufacturing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Cosmetic Peptide Manufacturing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Cosmetic Peptide Manufacturing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Cosmetic Peptide Manufacturing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Croda International PIc
  2. 8.1.1 Croda International PIc Company Information
  3. 8.1.2 Croda International PIc Business Overview
  4. 8.1.3 Croda International PIc Cosmetic Peptide Manufacturing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Croda International PIc Cosmetic Peptide Manufacturing Product Portfolio
  6. 8.1.5 Croda International PIc Recent Developments
  7. 8.2 Ashland
  8. 8.2.1 Ashland Company Information
  9. 8.2.2 Ashland Business Overview
  10. 8.2.3 Ashland Cosmetic Peptide Manufacturing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Ashland Cosmetic Peptide Manufacturing Product Portfolio
  12. 8.2.5 Ashland Recent Developments
  13. 8.3 DSM [Koninklijke DSM NV]
  14. 8.3.1 DSM [Koninklijke DSM NV] Company Information
  15. 8.3.2 DSM [Koninklijke DSM NV] Business Overview
  16. 8.3.3 DSM [Koninklijke DSM NV] Cosmetic Peptide Manufacturing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 DSM [Koninklijke DSM NV] Cosmetic Peptide Manufacturing Product Portfolio
  18. 8.3.5 DSM [Koninklijke DSM NV] Recent Developments
  19. 8.4 Bachem
  20. 8.4.1 Bachem Company Information
  21. 8.4.2 Bachem Business Overview
  22. 8.4.3 Bachem Cosmetic Peptide Manufacturing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bachem Cosmetic Peptide Manufacturing Product Portfolio
  24. 8.4.5 Bachem Recent Developments
  25. 8.5 Genscript Biotech Corp
  26. 8.5.1 Genscript Biotech Corp Company Information
  27. 8.5.2 Genscript Biotech Corp Business Overview
  28. 8.5.3 Genscript Biotech Corp Cosmetic Peptide Manufacturing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Genscript Biotech Corp Cosmetic Peptide Manufacturing Product Portfolio
  30. 8.5.5 Genscript Biotech Corp Recent Developments
  31. 8.6 BASF SE
  32. 8.6.1 BASF SE Company Information
  33. 8.6.2 BASF SE Business Overview
  34. 8.6.3 BASF SE Cosmetic Peptide Manufacturing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 BASF SE Cosmetic Peptide Manufacturing Product Portfolio
  36. 8.6.5 BASF SE Recent Developments
  37. 8.7 Geltor
  38. 8.7.1 Geltor Company Information
  39. 8.7.2 Geltor Business Overview
  40. 8.7.3 Geltor Cosmetic Peptide Manufacturing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Geltor Cosmetic Peptide Manufacturing Product Portfolio
  42. 8.7.5 Geltor Recent Developments
  43. 8.8 The Lubrizol Corporation
  44. 8.8.1 The Lubrizol Corporation Company Information
  45. 8.8.2 The Lubrizol Corporation Business Overview
  46. 8.8.3 The Lubrizol Corporation Cosmetic Peptide Manufacturing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 The Lubrizol Corporation Cosmetic Peptide Manufacturing Product Portfolio
  48. 8.8.5 The Lubrizol Corporation Recent Developments
  49. 8.9 Symrise
  50. 8.9.1 Symrise Company Information
  51. 8.9.2 Symrise Business Overview
  52. 8.9.3 Symrise Cosmetic Peptide Manufacturing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Symrise Cosmetic Peptide Manufacturing Product Portfolio
  54. 8.9.5 Symrise Recent Developments
  55. 8.10 Bio basic Inc.
  56. 8.10.1 Bio basic Inc. Company Information
  57. 8.10.2 Bio basic Inc. Business Overview
  58. 8.10.3 Bio basic Inc. Cosmetic Peptide Manufacturing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Bio basic Inc. Cosmetic Peptide Manufacturing Product Portfolio
  60. 8.10.5 Bio basic Inc. Recent Developments
  61. 8.11 Regeron Inc.
  62. 8.11.1 Regeron Inc. Company Information
  63. 8.11.2 Regeron Inc. Business Overview
  64. 8.11.3 Regeron Inc. Cosmetic Peptide Manufacturing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Regeron Inc. Cosmetic Peptide Manufacturing Product Portfolio
  66. 8.11.5 Regeron Inc. Recent Developments
  67. 8.12 Merck KGaA
  68. 8.12.1 Merck KGaA Company Information
  69. 8.12.2 Merck KGaA Business Overview
  70. 8.12.3 Merck KGaA Cosmetic Peptide Manufacturing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Merck KGaA Cosmetic Peptide Manufacturing Product Portfolio
  72. 8.12.5 Merck KGaA Recent Developments
  73. 8.13 RS Synthesis, LLC
  74. 8.13.1 RS Synthesis, LLC Company Information
  75. 8.13.2 RS Synthesis, LLC Business Overview
  76. 8.13.3 RS Synthesis, LLC Cosmetic Peptide Manufacturing Revenue and Gross Margin (2021-2026)
  77. 8.13.4 RS Synthesis, LLC Cosmetic Peptide Manufacturing Product Portfolio
  78. 8.13.5 RS Synthesis, LLC Recent Developments
  79. 8.14 CSBio Company Inc.
  80. 8.14.1 CSBio Company Inc. Company Information
  81. 8.14.2 CSBio Company Inc. Business Overview
  82. 8.14.3 CSBio Company Inc. Cosmetic Peptide Manufacturing Revenue and Gross Margin (2021-2026)
  83. 8.14.4 CSBio Company Inc. Cosmetic Peptide Manufacturing Product Portfolio
  84. 8.14.5 CSBio Company Inc. Recent Developments
  85. 8.15 Creative Peptides
  86. 8.15.1 Creative Peptides Company Information
  87. 8.15.2 Creative Peptides Business Overview
  88. 8.15.3 Creative Peptides Cosmetic Peptide Manufacturing Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Creative Peptides Cosmetic Peptide Manufacturing Product Portfolio
  90. 8.15.5 Creative Peptides Recent Developments
  91. 8.16 Spec Chem Industry Inc.
  92. 8.16.1 Spec Chem Industry Inc. Company Information
  93. 8.16.2 Spec Chem Industry Inc. Business Overview
  94. 8.16.3 Spec Chem Industry Inc. Cosmetic Peptide Manufacturing Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Spec Chem Industry Inc. Cosmetic Peptide Manufacturing Product Portfolio
  96. 8.16.5 Spec Chem Industry Inc. Recent Developments
  97. 8.17 LipoTrue, SL
  98. 8.17.1 LipoTrue, SL Company Information
  99. 8.17.2 LipoTrue, SL Business Overview
  100. 8.17.3 LipoTrue, SL Cosmetic Peptide Manufacturing Revenue and Gross Margin (2021-2026)
  101. 8.17.4 LipoTrue, SL Cosmetic Peptide Manufacturing Product Portfolio
  102. 8.17.5 LipoTrue, SL Recent Developments
  103. 8.18 Fibroheal
  104. 8.18.1 Fibroheal Company Information
  105. 8.18.2 Fibroheal Business Overview
  106. 8.18.3 Fibroheal Cosmetic Peptide Manufacturing Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Fibroheal Cosmetic Peptide Manufacturing Product Portfolio
  108. 8.18.5 Fibroheal Recent Developments
  109. 8.19 Seiwa Kasei Co., Ltd.
  110. 8.19.1 Seiwa Kasei Co., Ltd. Company Information
  111. 8.19.2 Seiwa Kasei Co., Ltd. Business Overview
  112. 8.19.3 Seiwa Kasei Co., Ltd. Cosmetic Peptide Manufacturing Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Seiwa Kasei Co., Ltd. Cosmetic Peptide Manufacturing Product Portfolio
  114. 8.19.5 Seiwa Kasei Co., Ltd. Recent Developments
  115. 8.20 Silab
  116. 8.20.1 Silab Company Information
  117. 8.20.2 Silab Business Overview
  118. 8.20.3 Silab Cosmetic Peptide Manufacturing Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Silab Cosmetic Peptide Manufacturing Product Portfolio
  120. 8.20.5 Silab Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst